Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company’s mCUBE platform accelerates data-driven drug discovery, biomarker identification and patient selection - to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies.